Microscopic Colitis Clinical Trial
Official title:
Efficacy and Safety of Budesonide for Treatment of Lymphocytic Colitis
The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis
The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05998174 -
Faecal Microbiota Transplantation for Microscopic Colitis
|
Early Phase 1 | |
| Recruiting |
NCT05058131 -
Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre
|
N/A | |
| Completed |
NCT02303132 -
Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis
|
N/A | |
| Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
| Recruiting |
NCT06031064 -
External Validation of a Microscopic Colitis Clinical Scoring System in Patients With Chronic Watery Diarrhoea
|
||
| Recruiting |
NCT04043897 -
Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis
|
Phase 2 | |
| Recruiting |
NCT06172647 -
Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal Cancer
|
||
| Recruiting |
NCT03477032 -
FMT in Inflammatory Bowel Disease
|
||
| Completed |
NCT03275467 -
Faecal Microbiota Transplantation in Patients With Microscopic Colitis
|
N/A | |
| Completed |
NCT01928667 -
Case-Control Study to Identify Risk Factors for Microscopic Colitis
|
N/A | |
| Not yet recruiting |
NCT05915104 -
Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis
|
Phase 2 | |
| Completed |
NCT00952952 -
Trial of Mesalamine for the Treatment of Active Microscopic Colitis
|
Phase 2/Phase 3 |